# LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE

NDC: 51662-1412
Generic name: LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Marketing started: 20191014

FDA application: NDA006488

## Active ingredients

- EPINEPHRINE BITARTRATE: .005 mg/mL
- LIDOCAINE HYDROCHLORIDE ANHYDROUS: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1412"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1412
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94e9f2db-af29-032e-e053-2995a90a7f7b